Brighter’s pioneering diabetes management solution Actiste® receives market approval in the United Arab Emirates
Brighter AB (publ) is proud to announce that its pioneering solution for improved diabetes management, Actiste®, has received market approval from the UAE Ministry of Health and Prevention (“MOHAP”). Some additional regulatory approvals for consumables included within the Actiste® Diabetes Management as a Service (“Actiste Service”) offering are still outstanding but underway. “The market approval in the UAE is a vital milestone allowing Brighter to start engaging with real-world patients and making a difference in their everyday life. We are glad to now be able to actively contribute to